摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(4-羟基-6-甲氧基-7-甲基-3-氧代-5-邻苯二甲酰基)-4-甲基-4-己烯酸三乙胺盐 | 66341-85-3

中文名称
6-(4-羟基-6-甲氧基-7-甲基-3-氧代-5-邻苯二甲酰基)-4-甲基-4-己烯酸三乙胺盐
中文别名
——
英文名称
triethylamine mycophenolate
英文别名
6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid triethylamine salt;mycophenolic acid triethylamine salt;mycophenolic acid triethylamine;Mycophenolate triethylamine;N,N-diethylethanamine;(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid
6-(4-羟基-6-甲氧基-7-甲基-3-氧代-5-邻苯二甲酰基)-4-甲基-4-己烯酸三乙胺盐化学式
CAS
66341-85-3
化学式
C6H15N*C17H20O6
mdl
——
分子量
421.534
InChiKey
UCVFIGBNEJKUIA-JOKMOOFLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.08
  • 重原子数:
    30
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    96.3
  • 氢给体数:
    2
  • 氢受体数:
    7

SDS

SDS:3c442f8503c42c1d4d29eb3cfd74efc6
查看

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] METHOD FOR THE PREPARATION OF MYCOPHENOLATE MOFETIL<br/>[FR] PROCÉDÉ DE PRÉPARATION DE MYCOPHÉNOLATE MOFÉTIL
    申请人:DSM IP ASSETS BV
    公开号:WO2009003878A1
    公开(公告)日:2009-01-08
    The present invention provides a method for the preparation of mycophenolate mofetil wherein mycophenolic acid or an amine salt of mycophenolic acid is esterified with 2-morpholinoethanol followed by downstream processing in the presence of a chelating agent (formula (I)).
    本发明提供了一种制备麦考酚酯酰甲酸酯的方法,其中麦考酚酸或麦考酚酸的胺盐与2-吗啉乙醇酯化,然后在螯合剂(式(I))存在下进行下游处理。
  • PROCESS FOR PREPARING MYCOPHENOLATE MOFETIL
    申请人:Choi Byoung Taek
    公开号:US20100298560A1
    公开(公告)日:2010-11-25
    The present invention relates to an improved method of manufacturing mycophenolate mofetil. More particularly, the present invention relates to a method of manufacturing mycophenolate mofetil with high purity comprising : a) converting mycophenolate to an amine salt by reacting with an amine base; and b) reacting the resultant with a halogenating agent and 2-morpholinoethanol continuously.
  • [EN] FORMULATIONS AND METHOD FOR TREATMENT OF INFLAMMATORY DISEASES<br/>[FR] FORMULATIONS ET MÉTHODE POUR LE TRAITEMENT DES MALADIES INFLAMMATOIRES
    申请人:VYOME THERAPEUTICS INC
    公开号:WO2021124301A1
    公开(公告)日:2021-06-24
    The present invention relates to formulations and their use to treat ocular disorders such as uveitis. Particularly, the invention relates to a formulation comprising mycophenolic acid (MPA) or a pharmaceutically acceptable salt or derivative thereof; and at least one component selected from the group consisting of preservative, chelating agent, buffering agent, pH modifier, thickening agent, viscosity enhancer or viscosity modifier, antioxidant, tonicity modifier, surfactant, humectant, solvent or co-solvent, emulsifier, co-emulsifier, ointment base, targeting agent, polymer, wetting agent, lubricating agent, suspending agent, and therapeutic agent. The disclosure further provides preparation method of said ophthalmic formulations, a pharmaceutical kit comprising said formulations, and method for treating ocular diseases by administering said formulations. The present formulations are advantageous and can be delivered to the eye with increased retention time in the eye and increased bioavailability of mycophenolic acid, or a pharmaceutically acceptable salt or derivative thereof in the eye.
  • [EN] IMPROVED PROCESS FOR PREPARING MYCOPHENOLATE MOFETIL<br/>[FR] PROCÉDÉ AMÉLIORÉ DE PRÉPARATION DE MYCOPHÉNOLATE DE MOFETIL
    申请人:CKD BIO CORP
    公开号:WO2009096668A3
    公开(公告)日:2010-05-27
  • [EN] ISOLATION AND USE OF AMINE SALTS OF MYCOPHENOLIC ACID<br/>[FR] ISOLATION ET UTILISATION DE SELS AMINÉS D'ACIDE MYCOPHÉNOLIQUE
    申请人:DSM IP ASSETS BV
    公开号:WO2008003637A3
    公开(公告)日:2008-05-08
查看更多